NASDAQ:APTO Aptose Biosciences (APTO) Earnings Date, Estimates & Call Transcripts $2.80 +0.04 (+1.45%) (As of 09/29/2023 08:52 PM ET) Add Compare Share Share Today's Range$2.78▼$2.9150-Day Range$2.76▼$5.0452-Week Range$2.76▼$11.85Volume44,800 shsAverage Volume27,666 shsMarket Capitalization$20.44 millionP/E RatioN/ADividend YieldN/APrice Target$38.50 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateNov. 7EstimatedActual EPS (Aug. 10) -$2.27 Missed By -$0.18 Consensus EPS (Aug. 10) -$2.09 Get Aptose Biosciences Earnings AlertsEnter your email address below to receive the latest news and earnings results for APTO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAPTO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.APTO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Aptose Biosciences Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20232($0.16)($0.12)($0.14)Q2 20233($2.29)($0.12)($0.86)Q3 20233($1.29)($0.10)($0.52)Q4 20233($1.43)($0.10)($0.57)FY 202311($5.17)($0.44)($2.10)APTO Earnings Date and InformationAptose Biosciences last issued its quarterly earnings results on August 10th, 2023. The biotechnology company reported ($2.27) earnings per share for the quarter, missing analysts' consensus estimates of ($2.09) by $0.18. Aptose Biosciences has generated ($7.82) earnings per share over the last year (($7.82) diluted earnings per share). Earnings for Aptose Biosciences are expected to grow in the coming year, from ($8.65) to ($7.14) per share. Aptose Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off prior year's report dates.Read More Aptose Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 11/7/2023Estimated)------- 8/10/2023Q2 2023($2.09)($2.27)($0.18)($2.27)--5/8/2023Q1 2023($1.80)($2.25)($0.45)($2.25)--3/23/2023Q4 2022($1.65)($1.65)-($0.11)-- 11/1/2022Q3 2022($1.80)($1.65)+$0.15($0.11)--8/2/2022Q2 2022($1.95)($1.65)+$0.30($0.11)--5/9/2022Q1 2022($2.25)($1.80)+$0.45($0.12)-- Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 3/22/2022Q4 2021($2.70)($4.05)($1.35)($0.27)-- 11/11/2021Q3 2021($2.55)($1.95)+$0.60($0.13)-- 8/2/2021Q2 2021($2.85)($2.25)+$0.60($0.15)-- 5/4/2021Q1 2021($2.55)($2.70)($0.15)($0.18)-- 3/22/2021Q4 2020($2.55)($2.40)+$0.15($0.17)-- 11/15/2020Q3($2.70)($2.25)+$0.45($0.15)-- Aptose Biosciences Earnings - Frequently Asked Questions When is Aptose Biosciences's earnings date? Aptose Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 7th, 2023 based off last year's report dates. Learn more on APTO's earnings history. Did Aptose Biosciences beat their earnings estimates last quarter? In the previous quarter, Aptose Biosciences (NASDAQ:APTO) missed the analysts' consensus estimate of ($2.09) by $0.18 with a reported earnings per share (EPS) of ($2.27). Learn more on analysts' earnings estimate vs. APTO's actual earnings. How much profit does Aptose Biosciences generate each year? Aptose Biosciences (NASDAQ:APTO) has a recorded net income of -$41.82 million. APTO has generated -$7.82 earnings per share over the last four quarters. What is Aptose Biosciences's EPS forecast for next year? Aptose Biosciences's earnings are expected to grow from ($8.65) per share to ($7.14) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Senti Biosciences Earnings Evaxion Biotech A/S Earnings Elutia Earnings Entera Bio Earnings Axcella Health Earnings Protara Therapeutics Earnings Acorda Therapeutics Earnings Pluri Earnings Brainstorm Cell Therapeutics Earnings AIM ImmunoTech Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: CarMax Slides On Earnings Disappointment, Time To Celebrate?5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 EarningsDoes Ciena's Earnings Beat Signal New Networking Boom Ahead?The 5 Most Upgraded Stocks From Q2 Earnings Reporting SeasonNordstrom: 3 Reasons the Pre-Earnings Dip Is an OpportunityWhat Ross Stores Earnings Say About The Saver Shopping Economy3 Ways To Trade, Trade Desk Stock Post Earnings This page (NASDAQ:APTO) was last updated on 10/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.